Mutated Lacto-N-Biosidase with Improved Properties from Bifidobacterium Longum
Summary
The USPTO published patent application US20260110008A1 for mutated lacto-N-biosidase enzymes with improved properties derived from Bifidobacterium longum. The application names five inventors: Birgitte Zeuner, Jan Muschiol, Marlene Isabelle Vuillemin, Anne Merete Boye Strunge Meyer, and Jesper Holck. Filing date was December 14, 2023, under application number 19138531. The patent application does not impose compliance obligations but may affect competitive R&D strategy in enzyme biotechnology and related sectors.
“Mutated lacto-N-biosidases are provided with improved properties compared to the wild type lacto-N-biosidase isolated from Bifidobacterium longum.”
About this source
GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 263 changes logged to date.
What changed
The USPTO published patent application US20260110008A1 for mutated lacto-N-biosidase enzymes derived from Bifidobacterium longum with improved properties compared to the wild-type enzyme. The application names five inventors and was filed December 14, 2023 under application number 19138531, with CPC classifications in C12P 19/26, C12N 9/2402, and C12Y 302/0114. Patent applications do not create compliance obligations but establish intellectual property rights that may affect competitive R&D strategies in the enzyme biotechnology sector.
For entities in the biotech and pharmaceutical industries, this published application signals potential freedom-to-operate considerations for lacto-N-biosidase enzyme development. Companies developing similar enzyme products should review their own IP portfolios and assess whether the claimed mutations may overlap with their R&D programs. Patent prosecution will continue before any patent grant.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MUTATED LACTO-N-BIOSIDASE
Application US20260110008A1 Kind: A1 Apr 23, 2026
Inventors
Birgitte ZEUNER, Jan MUSCHIOL, Marlene Isabelle VUILLEMIN, Anne Merete Boye Strunge MEYER, Jesper HOLCK
Abstract
Mutated lacto-N-biosidases are provided with improved properties compared to the wild type lacto-N-biosidase isolated from Bifidobacterium longum.
CPC Classifications
C12P 19/26 C12N 9/2402 C12Y 302/0114
Filing Date
2023-12-14
Application No.
19138531
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.